Enveric Biosciences (ENVB) Competitors $0.91 -0.10 (-9.90%) Closing price 04:00 PM EasternExtended Trading$0.93 +0.02 (+1.76%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENVB vs. PRPH, SNGX, NXTC, LGVN, FLGC, TXMD, BIVI, BFRG, LPTX, and HCWBShould you be buying Enveric Biosciences stock or one of its competitors? The main competitors of Enveric Biosciences include ProPhase Labs (PRPH), Soligenix (SNGX), NextCure (NXTC), Longeveron (LGVN), Flora Growth (FLGC), TherapeuticsMD (TXMD), BioVie (BIVI), Bullfrog AI (BFRG), Leap Therapeutics (LPTX), and HCW Biologics (HCWB). These companies are all part of the "pharmaceutical products" industry. Enveric Biosciences vs. Its Competitors ProPhase Labs Soligenix NextCure Longeveron Flora Growth TherapeuticsMD BioVie Bullfrog AI Leap Therapeutics HCW Biologics Enveric Biosciences (NASDAQ:ENVB) and ProPhase Labs (NASDAQ:PRPH) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, valuation and dividends. Do analysts recommend ENVB or PRPH? Enveric Biosciences currently has a consensus price target of $10.00, indicating a potential upside of 998.90%. Given Enveric Biosciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe Enveric Biosciences is more favorable than ProPhase Labs.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enveric Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00ProPhase Labs 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor ENVB or PRPH? In the previous week, ProPhase Labs had 3 more articles in the media than Enveric Biosciences. MarketBeat recorded 3 mentions for ProPhase Labs and 0 mentions for Enveric Biosciences. Enveric Biosciences' average media sentiment score of 0.90 beat ProPhase Labs' score of -0.33 indicating that Enveric Biosciences is being referred to more favorably in the media. Company Overall Sentiment Enveric Biosciences Positive ProPhase Labs Neutral Do insiders & institutionals believe in ENVB or PRPH? 13.8% of Enveric Biosciences shares are owned by institutional investors. Comparatively, 9.4% of ProPhase Labs shares are owned by institutional investors. 1.1% of Enveric Biosciences shares are owned by company insiders. Comparatively, 9.6% of ProPhase Labs shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, ENVB or PRPH? Enveric Biosciences has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Comparatively, ProPhase Labs has a beta of -0.78, indicating that its stock price is 178% less volatile than the S&P 500. Which has better valuation and earnings, ENVB or PRPH? Enveric Biosciences has higher earnings, but lower revenue than ProPhase Labs. ProPhase Labs is trading at a lower price-to-earnings ratio than Enveric Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnveric BiosciencesN/AN/A-$9.57M-$38.38-0.02ProPhase Labs$5.59M2.64-$53.36M-$1.26-0.28 Is ENVB or PRPH more profitable? ProPhase Labs' return on equity of -262.42% beat Enveric Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Enveric BiosciencesN/A -341.48% -240.71% ProPhase Labs N/A -262.42%-76.48% SummaryEnveric Biosciences beats ProPhase Labs on 8 of the 14 factors compared between the two stocks. Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ENVB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENVB vs. The Competition Export to ExcelMetricEnveric BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.28M$3.12B$5.77B$9.91BDividend YieldN/A2.29%6.71%4.52%P/E Ratio-0.0220.9775.5426.08Price / SalesN/A291.86482.3289.52Price / CashN/A44.9736.9659.01Price / Book0.399.8611.446.09Net Income-$9.57M-$53.47M$3.28B$266.14M7 Day Performance-19.47%2.89%0.84%0.28%1 Month Performance-24.79%8.62%7.15%4.14%1 Year Performance-88.49%13.69%59.66%23.93% Enveric Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENVBEnveric Biosciences3.3187 of 5 stars$0.91-9.9%$10.00+998.9%-86.7%$3.28MN/A-0.0220PRPHProPhase Labs0.2883 of 5 stars$0.33-2.1%N/A-86.2%$13.75M$6.77M-0.26130Short Interest ↑SNGXSoligenix2.6609 of 5 stars$3.09-0.3%$6.00+94.2%-25.3%$13.26M$120K-0.8120Positive NewsShort Interest ↓NXTCNextCure4.6363 of 5 stars$4.90-2.6%$25.50+420.4%-71.8%$13.13MN/A-0.1990News CoveragePositive NewsShort Interest ↓LGVNLongeveron2.6126 of 5 stars$0.830.0%$7.67+825.9%-65.5%$12.51M$2.07M-0.1320Short Interest ↑FLGCFlora Growth2.3018 of 5 stars$21.50+5.1%$93.00+332.6%-42.7%$12.45M$52.37M-0.63280Short Interest ↑Gap DownTXMDTherapeuticsMD0.2247 of 5 stars$1.08-3.6%N/A-38.6%$12.32M$1.76M0.00420Positive NewsBIVIBioVie0.3653 of 5 stars$1.62+6.6%N/A-94.0%$12.23MN/A-0.0210BFRGBullfrog AI0.7645 of 5 stars$1.21flatN/A-50.2%$12.15M$60K-1.594LPTXLeap Therapeutics1.519 of 5 stars$0.29+1.6%$3.38+1,051.9%-90.3%$12.14MN/A-0.1940HCWBHCW Biologics3.2043 of 5 stars$5.58-2.5%$35.00+527.8%-74.3%$12.03M$2.57M-0.4040Short Interest ↓ Related Companies and Tools Related Companies PRPH Alternatives SNGX Alternatives NXTC Alternatives LGVN Alternatives FLGC Alternatives TXMD Alternatives BIVI Alternatives BFRG Alternatives LPTX Alternatives HCWB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ENVB) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENVB Stock Alerts